Zdrowie i gospodarka · 9.04.2025
FDA Clears Doxycycline Oral Suspension for Continued Approval
The FDA has determined that doxycycline oral suspension, 25mg/5mL, was not withdrawn from sale due to safety or effectiveness concerns. This decision allows the FDA to continue approving ANDAs for this product as long as they meet regulatory requirements.